Rutgers University Study of the Genetics of Blood Cancers

This study from Rutgers University is looking at the genes that might affect your risk of developing blood cancers like leukemia, lymphoma, and myeloma. There are no specific treatments or drugs being tested. Instead, researchers want to find new genetic differences and learn more about known ones related to these cancers. You can join if you are 18 or older, live in the US, and have internet access. The goal is to enroll 10,000 people. Success for this study means identifying genetic risk variants (changes in your genes that might increase your risk) associated with blood cancer within two years. The current recruitment status is unclear.

Study design
This is an observational study aiming to enroll 10,000 participants. It is an online research study.
What's involved
You will complete an online survey about your health and provide a saliva sample using a kit mailed to your home. This takes about 20 minutes.
Compensation
You may receive information about your genetic ancestry for free. Not stated in the trial record if there is other compensation.
Follow-up
Genetic risk variants associated with blood cancer will be measured at 2 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07714044

Rutgers University Study of the Genetics of Blood Cancers

Not Yet Recruiting
Not specifiedAges 18+Observational
Rutgers, The State University of New Jersey
~10,000 participants
Updated 2026-07-20 on ClinicalTrials.gov

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Genetic risk variants associated with blood cancer
Measured over 2 years
Blood Cancers
Blood Cancer
Leukemia
Lymphoma
Myeloma
Hematologic Cancer
Hematologic Malignancies
Hematologic Neoplasm
Hematologic Tumors
1 sites across 1 states
New Jersey1
  • Tara Matise, PhD · PRINCIPAL_INVESTIGATOR · Rutgers University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

age 18 years or older
currently living in the United States
have access to the internet and a computer, laptop, tablet or smartphone
willing to provide written informed consent for participation
willing to provide DNA via a saliva sample using a collection kit mailed to your home
willing to complete a survey with questions about health related to the study of blood cancer.
  • Genetic risk variants associated with blood cancer2 years

    Genetic factors will be measured through whole exome sequencing and genome-wide genotyping array, and then correlated with blood cancer subtype.